Philip Lee is an internationally recognised firm in the pharmaceutical and life science sectors.
Our clients choose us for our detailed technical knowledge and our breadth and depth of experience across all areas of law and policy that affect business in these sectors.
We work with globally acclaimed medical technology companies as well as multinational pharmaceutical companies, and are proud of our work with start-up and early stage companies too.
We have developed invaluable relationships with key stakeholders in the Irish healthcare system. The firm is an affiliate member of the Irish Pharmaceutical Healthcare Association (IPHA) and is a member of the Irish Business and Employers Confederation (Ibec) which includes a specialist group concentrating on the medical devices and med tech sectors.
We advise many of the world’s leading pharmaceutical companies on all aspects of their operations in Ireland, including in relation to clinical research, clinical trial arrangements, licensing and other pharmaceutical-regulatory issues, dealings with the Healthcare Products Regulatory Authority, distribution arrangements, market access, competition law issues, outsourced service arrangements, sponsorship and funding issues, pricing and reimbursement, public sector procurement of medicines, and in relation to advertising and marketing activities.
Members of our team also have in-depth experience in advising global and domestic players in the pharma sector on M&A, corporate transactional and equity (including IPOs) and debt fundraisings, including on the use of Ireland as a platform for multi-lateral activities.
Our intellectual property team frequently advises our pharmaceutical clients on issues such as patent infringement, patent life cycles, data and marketing exclusivity issues, trade mark infringement via parallel importation and copyright issues.
Our team members are experts in data protection and privacy, which are important issues for our pharmaceutical sector clients.
As with our other core areas, we work to ensure that we have the expertise and market knowledge to exceed our clients’ expectations.
Life Sciences (including medical devices and medical technologies)
We advise a large number of leading international medical device companies as well as many early stage and developing companies in this sector.
Our work is wide-ranging, and includes advising our clients on their research arrangements, clinical investigations, licensing and regulatory requirements (including in relation to obtaining CE marking), technology licensing issues, data protection and privacy issues (including in relation to patient consent), distribution arrangements, market access and in relation to advertising and marketing.
The life sciences and pharmaceuticals group has particular experience in competition and antitrust matters, along with commercial disputes, intellectual property and data protection issues.
Legal 500, 2023
The healthcare and life sciences department in Philip Lee is exceptional.
Legal 500, 2021
Recent transactions and projects
Scientific Laboratory Supplies (SLS), the UK’s leading supplier of laboratory equipment, chemicals and consumables, has acquired Dublin-based Sparks Lab Supplies, expanding its product and service offering in the Republic of Ireland. Nottingham headquartered SLS has...
Groupe RG, a major player in the distribution of PPE in France, has acquired PPE specialist MJ Scannell in Ireland. The acquisition forms part of Groupe RG’s development strategy to become the independent and specialist leader of PPE distribution throughout Europe....
Acting for private equity fund Duke Street on the Irish aspects of the acquisition of DCC’s generic drug business with operations in Ireland and Britain. The deal included British drugs business Kent Pharmaceuticals and an associated Irish manufacturer, Athlone...
News and insights
Key Contacts: Ronan Dunne - Partner | Marie Kinsella - Partner Welcome to the latest update from the Philip Lee Healthcare, Pharmaceutical and Life Science group in respect of the first quarter of 2023. This update covers a range of topics: General Regulatory –...
Key Contact: Ronan Dunne - Partner | Marie Kinsella - Partner Welcome to the latest update from the Philip Lee Healthcare, Pharmaceutical and Life Science group in respect of the fourth quarter of 2022.This update covers a range of topics: General Regulatory –...
Key Contact: Ronan Dunne - Partner | Maire Kinsella - Partner Welcome to the latest update from the Philip Lee Healthcare, Pharmaceuticals and Life Science group. This update covers a range of topics: General Regulatory – Ireland 1. Irish Government publishes...